Earnings
NeuroPace Lost Routine Surgeon Contact After Distribution Exit — Its CEO Says It Can Stay Out
The company cut its revenue outlook to $91 million–$92 million as disrupted implant accounts and sales-team changes slowed growth.
NeuroPace (NPCE) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
The company cut its revenue outlook to $91 million–$92 million as disrupted implant accounts and sales-team changes slowed growth.
SEC Filings
Lower spending narrowed the quarterly loss, but NeuroPace now expects a larger adjusted EBITDA loss for the year.